Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study

20260 citationsJournal Articlegold Open Access

Authors

NCT03845400, registered February 19, 2019.

Published in: Allergy Asthma and Clinical Immunology

Volume 22, Issue 1

Field-Weighted Citation Impact: 0.00